3. As of noon trading, DaVita HealthCare Partners ( DVA) is down $0.37 (-0.6%) to $64.60 on light volume. Thus far, 395,108 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $64.52-$65.00 after having opened the day at $65.00 as compared to the previous trading day's close of $64.97.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.7 billion and is part of the health care sector. The company has a P/E ratio of 24.2, above the S&P 500 P/E ratio of 17.7. Shares are up 2.5% year-to-date as of the close of trading on Tuesday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

WuXi PharmaTech (WX) Showing Signs Of Being Strong And Under The Radar

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Strong And Under The Radar Today: WuXi PharmaTech (WX)

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)